
|Articles|July 2, 2004
- Pharmaceutical Technology-07-02-2004
- Volume 28
- Issue 7
Politics Versus Science in Biomedical Research and Development
Author(s)Jill Wechsler
Decisions to accelerate the approval of AIDS combination drugs, reject the over-the-counter status for the morning-after pill, and limit support for stem cell research are hot political topics.
Advertisement
Articles in this issue
almost 22 years ago
3M Drug Delivery Systemsalmost 22 years ago
AccuRatealmost 22 years ago
July 2004almost 22 years ago
Investors Shy Away from Pharmaceutical Chemicalsalmost 22 years ago
In the Spotlight-July 2004almost 22 years ago
A Stability Program for the Distribution of Drug ProductsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
3
Investigating Patient Complaints About Combination Products
4
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
5




